SCHEMBL5457475

SCHEMBL5457475

Cc1cc2c(-c3cc(-c4ccccc4)c4ccc5c(-c6ccccc6)ccnc5c4n3)cccc2c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 3/20 0.40
CCR8 P51685 3/20 0.40
TOP2A P11388 1/20 0.37
CCR5 P51681 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ACACA Q13085 2/20 0.35
MMP2 P08253 1/20 0.35
TOP1 P11387 2/20 0.35
PLG P00747 1/20 0.35
CKS1B P61024 1/20 0.35
GLO1 Q04760 1/20 0.35
SKP2 Q13309 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
KDM4E B2RXH2 2/20 0.34
PIK3CD O00329 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14581505 0.93 CCR1 (0.41) CCR1CCR8TOP2ACCR5L3MBTL1
SCHEMBL5463115 0.91 TOP1 (0.39) TOP2AACACAMMP2TOP1PLG
SCHEMBL14581506 0.90 TOP1 (0.42) TOP2AACACAMMP2TOP1PLG
SCHEMBL14581501 0.89 CCR1 (0.42) CCR1CCR8TOP2ACCR5L3MBTL1
SCHEMBL1228190 0.86 PDE4A (0.41) CCR1CCR8TOP2ACCR5L3MBTL1
SCHEMBL5452946 0.86 TNF (0.44) TOP2AL3MBTL1TOP1PLGDYRK1A
SCHEMBL5466842 0.85 TOP2A (0.42) TOP2AACACAMMP2TOP1PLG
SCHEMBL5456861 0.83 TOP1 (0.43) CCR1CCR8TOP2ACCR5L3MBTL1
SCHEMBL14581504 0.82 TOP2A (0.44) TOP2AACACATOP1PLGCKS1B
SCHEMBL14581513 0.81 ALDH1A1 (0.43) CCR1CCR8TOP2ACCR5L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070037983-A1 Phenanthroline derivative compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037983-A1 Phenanthroline derivative compound POP1, PABPC1, NAP1L1 CCR1 2669/4885CCR8 4103/4885TOP2A 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.